These data suggest that the molecular basis of FSHD might not be simply based on the overexpression of the single DUX4 gene, but rather from a cascade of dysregulation mediated by the D4Z4 array contraction. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.